AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Our findings suggest an increasing gap in diabetes prevalence between the most and least genetically susceptible. This suggests that people with a high genetic susceptibility to type 2 diabetes could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results